MedTrace Logo

BradyXplore Phase II: Bradykinesia Feature Extraction System

NCT02358876 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2016-10-06

Study results available
· View outcomes & findings →

Summary

Study objectives are to improve motion sensor algorithms for measuring bradykinesia in the clinic and the home, evaluate test-retest reliability of motion sensor algorithms for measuring bradykinesia compared to clinician raters, determine if participant-perceived symptom severities correlate with motion sensor measures, determine if speed, amplitude, and rhythm fluctuate differentially throughout the day in individuals with implanted deep brain stimulation systems, receive feedback on the usability of Kinesia One, and evaluate Kinesia One compliance in the home.

Conditions

Sponsors & Collaborators

  • University of Cincinnati

    collaborator OTHER

  • The Cleveland Clinic

    collaborator OTHER

  • Great Lakes NeuroTechnologies Inc.

    lead INDUSTRY

Principal Investigators

  • Dustin A Heldman, PhD · Great Lakes NeuroTechnologies

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02358876 on ClinicalTrials.gov